{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:08:27Z","timestamp":1783966107879,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Science and Technology Development Fund of The Affiliated Hospital of Xuzhou Medical University","award":["ZX202507"],"award-info":[{"award-number":["ZX202507"]}]},{"name":"Xuzhou Medical University Jiangsu Provincial Key Laboratory Open Research Project","award":["XZSYSKF2024025"],"award-info":[{"award-number":["XZSYSKF2024025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging. Inform. med."],"DOI":"10.1007\/s10278-026-02108-6","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:02:32Z","timestamp":1783965752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Multimodal, Multitask Prediction Framework for Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma"],"prefix":"10.1007","author":[{"given":"ChengYue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinYing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChengShuai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"11","key":"2108_CR1","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.annonc.2024.07.727","volume":"35","author":"NM Tannir","year":"2024","unstructured":"Tannir NM, Albig\u00e8s L, McDermott DF, Burotto M, Choueiri TK, Hammers HJ, et al. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial. Ann Oncol 2024;35(11):1026-38.","journal-title":"Ann Oncol"},{"issue":"5","key":"2108_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol 2022;82(5):529-42.","journal-title":"Eur Urol"},{"issue":"1","key":"2108_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-024-02059-y","volume":"23","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Jin Y, Zhou J, Chen F, Chen M, Gao Z, et al. PD1\/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives. Mol Cancer 2024;23(1):146.","journal-title":"Mol Cancer"},{"issue":"1","key":"2108_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.21869","volume":"4","author":"S Dudani","year":"2021","unstructured":"Dudani S, de Velasco G, Wells JC, Gan CL, Donskov F, Porta C, et al. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival. JAMA Netw Open 2021;4(1):e2021869.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2108_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.eururo.2021.04.042","volume":"80","author":"J Bedke","year":"2021","unstructured":"Bedke J, Albiges L, Capitanio U, Giles RH, Hora M, Lam TB, et al. The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care. Eur Urol 2021;80(4):393-7.","journal-title":"Eur Urol"},{"issue":"1","key":"2108_CR6","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1186\/s12885-025-14562-6","volume":"25","author":"J Bai","year":"2025","unstructured":"Bai J, Huang J, Ye Y, Lin J, Wen Y, Cai Z, et al. Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study. BMC Cancer 2025;25(1):1152.","journal-title":"BMC Cancer"},{"issue":"23","key":"2108_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers16234034","volume":"16","author":"AE Quinn","year":"2024","unstructured":"Quinn AE, Bell SD, Marrah AJ, Wakefield MR, Fang Y. The Current State of the Diagnoses and Treatments for Clear Cell Renal Cell Carcinoma. Cancers (Basel) 2024;16(23):1.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2108_CR8","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ccell.2022.09.012","volume":"40","author":"J Lipkova","year":"2022","unstructured":"Lipkova J, Chen RJ, Chen B, Lu MY, Barbieri M, Shao D, et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell 2022;40(10):1095-110.","journal-title":"Cancer Cell"},{"issue":"2","key":"2108_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00129039-200406000-00010","volume":"12","author":"F Lin","year":"2004","unstructured":"Lin F, Brown RE, Shen T, Yang XJ, Schuerch C. Immunohistochemical detection of P504S in primary and metastatic renal cell carcinomas. Appl Immunohistochem Mol Morphol 2004;12(2):153-9.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2108_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2024.152297","volume":"71","author":"P Rotterova","year":"2024","unstructured":"Rotterova P, Alaghehbandan R, Skopal J, Rogala J, Slisarenko M, Strakova Peterikova A, et al. Alpha-methyl CoA racemase (AMACR) reactivity across the spectrum of clear cell renal cell neoplasms. Ann Diagn Pathol 2024;71:152297.","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"2108_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.21037\/tau-23-518","volume":"13","author":"H Han","year":"2024","unstructured":"Han H, Yin SY, Song RX, Zhao J, Yu YW, He MX, et al. Papillary renal neoplasm with reverse polarity: an observational study of histology, immunophenotypes, and molecular variation. Transl Androl Urol 2024;13(3):383-96.","journal-title":"Transl Androl Urol"},{"issue":"1","key":"2108_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13000-023-01315-x","volume":"18","author":"B Yang","year":"2023","unstructured":"Yang B, Sun L, Cao WF, Qi LS, Guo YH, Sun Y. Clear cell renal cell carcinoma with cystic component similar to multilocular cystic renal neoplasm of low malignant potential: a rare pattern of cyst-dependent progression from multilocular cystic renal neoplasm of low malignant potential. Diagn Pathol 2023;18(1):27.","journal-title":"Diagn Pathol"},{"key":"2108_CR13","doi-asserted-by":"publisher","first-page":"1591489","DOI":"10.3389\/fimmu.2025.1591489","volume":"16","author":"W Wang","year":"2025","unstructured":"Wang W, Chen M, Xue W, Zeng D. Combination therapy with toripalimab and lenvatinib in metastatic type 2 papillary renal cell carcinoma: a Case Report. Front Immunol 2025;16:1591489.","journal-title":"Front Immunol"},{"issue":"2","key":"2108_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41568-021-00408-3","volume":"22","author":"KM Boehm","year":"2022","unstructured":"Boehm KM, Khosravi P, Vanguri R, Gao J, Shah SP. Harnessing multimodal data integration to advance precision oncology. Nat Rev Cancer 2022;22(2):114-26.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2108_CR15","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/s43018-022-00436-4","volume":"3","author":"A Shmatko","year":"2022","unstructured":"Shmatko A, Ghaffari Laleh N, Gerstung M, Kather JN. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology. Nat Cancer 2022;3(9):1026-38.","journal-title":"Nat Cancer"},{"issue":"1","key":"2108_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11547-023-01730-6","volume":"129","author":"CY Lin","year":"2024","unstructured":"Lin CY, Guo SM, Lien JJ, Lin WT, Liu YS, Lai CH, et al. Combined model integrating deep learning, radiomics, and clinical data to classify lung nodules at chest CT. Radiol Med 2024;129(1):56-69.","journal-title":"Radiol Med"},{"issue":"1","key":"2108_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13045-022-01225-3","volume":"15","author":"R Wang","year":"2022","unstructured":"Wang R, Dai W, Gong J, Huang M, Hu T, Li H, et al. Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients. J Hematol Oncol 2022;15(1):11.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2108_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s42256-023-00633-5","volume":"5","author":"S Steyaert","year":"2023","unstructured":"Steyaert S, Pizurica M, Nagaraj D, Khandelwal P, Hernandez-Boussard T, Gentles AJ, et al. Multimodal data fusion for cancer biomarker discovery with deep learning. Nat Mach Intell 2023;5(4):351-62.","journal-title":"Nat Mach Intell"},{"issue":"3","key":"2108_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2024-011149","volume":"13","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Luo T, Yan M, Shen H, Tao K, Zeng J, et al. Voxel-level radiomics and deep learning for predicting pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant immunotherapy and chemotherapy. J Immunother Cancer 2025;13(3):1.","journal-title":"J Immunother Cancer"},{"issue":"13","key":"2108_CR20","first-page":"1","volume":"14","author":"LA Aldakhil","year":"2024","unstructured":"Aldakhil LA, Alhasson HF, Alharbi SS. Attention-Based Deep Learning Approach for Breast Cancer Histopathological Image Multi-Classification. Diagnostics (Basel) 2024;14(13):1.","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"2108_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000530352","volume":"120","author":"T Tian","year":"2023","unstructured":"Tian T, Gan T, Chen J, Lu J, Zhang G, Zhou Y, et al. Graphic Intelligent Diagnosis of Hypoxic-Ischemic Encephalopathy Using MRI-Based Deep Learning Model. Neonatology 2023;120(4):441-9.","journal-title":"Neonatology"},{"key":"2108_CR22","doi-asserted-by":"crossref","unstructured":"Fu Q, Wu Y, Zhu M, Xia Y, Yu Q, Liu Z, et al. Identifying cardiovascular disease risk in the U.S. population using environmental volatile organic compounds exposure: A machine learning predictive model based on the SHAP methodology. Ecotoxicol Environ Saf 2024;286:117210.","DOI":"10.1016\/j.ecoenv.2024.117210"},{"issue":"11","key":"2108_CR23","doi-asserted-by":"publisher","first-page":"8198","DOI":"10.1097\/JS9.0000000000003078","volume":"111","author":"L Wu","year":"2025","unstructured":"Wu L, Cen C, Ouyang D, Zhang L, Li X, Wu H, et al. Interpretable machine learning model for predicting early recurrence of pancreatic cancer: integrating intratumoral and peritumoral radiomics with body composition. Int J Surg 2025;111(11):8198-211.","journal-title":"Int J Surg"},{"key":"2108_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.979613","volume":"12","author":"F Yin","year":"2022","unstructured":"Yin F, Zhang H, Qi A, Zhu Z, Yang L, Wen G, et al. An exploratory study of CT radiomics using differential network feature selection for WHO\/ISUP grading and progression-free survival prediction of clear cell renal cell carcinoma. Front Oncol 2022;12:979613.","journal-title":"Front Oncol"},{"issue":"8","key":"2108_CR25","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1097\/JS9.0000000000002641","volume":"111","author":"R Zhu","year":"2025","unstructured":"Zhu R, Zhang Y, Zhang J, Yang H, Pan C, Li J, et al. Development and validation of an explainable machine learning model for predicting occult lymph node metastasis in early-stage oral tongue squamous cell carcinoma: A multi-center study. Int J Surg 2025;111(8):5022-35.","journal-title":"Int J Surg"},{"key":"2108_CR26","doi-asserted-by":"publisher","first-page":"1482020","DOI":"10.3389\/fimmu.2024.1482020","volume":"15","author":"F Guo","year":"2024","unstructured":"Guo F, Sun S, Deng X, Wang Y, Yao W, Yue P, et al. Predicting axillary lymph node metastasis in breast cancer using a multimodal radiomics and deep learning model. Front Immunol 2024;15:1482020.","journal-title":"Front Immunol"},{"issue":"8","key":"2108_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00262-024-03724-3","volume":"73","author":"W Caii","year":"2024","unstructured":"Caii W, Wu X, Guo K, Chen Y, Shi Y, Chen J. Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients. Cancer Immunol Immunother 2024;73(8):153.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2108_CR28","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S2589-7500(21)00215-6","volume":"4","author":"L Feng","year":"2022","unstructured":"Feng L, Liu Z, Li C, Li Z, Lou X, Shao L, et al. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digit Health 2022;4(1):e8-e17.","journal-title":"Lancet Digit Health"},{"issue":"25","key":"2108_CR29","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1200\/JCO.22.00868","volume":"40","author":"WK Rathmell","year":"2022","unstructured":"Rathmell WK, Rumble RB, Van Veldhuizen PJ, Al-Ahmadie H, Emamekhoo H, Hauke RJ, et al. Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline. J Clin Oncol 2022;40(25):2957-95.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2108_CR30","doi-asserted-by":"publisher","first-page":"8737","DOI":"10.1007\/s00330-022-08887-0","volume":"32","author":"Y Wang","year":"2022","unstructured":"Wang Y, Lang J, Zuo JZ, Dong Y, Hu Z, Xu X, et al. The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study. Eur Radiol 2022;32(12):8737-47.","journal-title":"Eur Radiol"}],"container-title":["Journal of Imaging Informatics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-026-02108-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-026-02108-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-026-02108-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:02:33Z","timestamp":1783965753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-026-02108-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":30,"alternative-id":["2108"],"URL":"https:\/\/doi.org\/10.1007\/s10278-026-02108-6","relation":{},"ISSN":["2948-2933"],"issn-type":[{"value":"2948-2933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Institutional Review Board of Xuzhou Medical University, and informed consent was not required due to the retrospective design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in figures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}